Management Archives - Page 22 of 56 - HIV Management Guidelines

Ensuring engagement and a person-centred approach

Promoting, nurturing and supporting engagement is best realised by providing: support education service coordination. Importantly person-centred approaches need to be adopted to ensure the highest attainable standard of health for people living with HIV and people at risk of HIV acquisition. Person-centred approaches include: centre a person’s autonomy, dignity and rights respect a person’s decisions …

Ensuring engagement and a person-centred approach Read More »

Contact tracing

Contact tracing is an essential part of the management of a person newly diagnosed with HIV but should rarely be the priority in the initial encounter. People with HIV can experience significant discrimination and rejection. There are implications for employment, relationships, insurance and immigration unless there is a possibility of providing post-exposure prophylaxis (PEP) to …

Contact tracing Read More »

References

King J, McManus H, Kwon A, Gray R, & McGregor S. HIV, viral hepatitis and sexually transmissible infections in Australia: Annual Surveillance Report 2023. Sydney: The Kirby Institute UNSW: 2023. Available at https://www.kirby.unsw.edu.au/sites/default/files/documents/Annual-Surveillance-Report-2023_HIV.pdf (accessed 11 June 2024). Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with …

References Read More »

Microbicides for the prevention of HIV infection

Gilda Tachedjian Burnet Institute, Melbourne, VIC Last reviewed: August 2019 Background Microbicides are chemical entities that can be formulated in gels, films, tablets, capsules or intravaginal rings (IVR) for application to the vagina or rectum to prevent the transmission of HIV and other sexually transmissible infections (1, 2). While male condoms are known to protect …

Microbicides for the prevention of HIV infection Read More »

Burden of HIV infection in women globally and in Australia

Despite major advances in HIV treatment and prevention, HIV infection remains a significant global health threat including in women. In 2017, around 7000 adolescent girls and young women became infected with HIV every week (9). Most of this burden is in sub-Saharan Africa where around 3 out of 4 new HIV infections occur in 15-19 …

Burden of HIV infection in women globally and in Australia Read More »

Microbicides demonstrating efficacy in clinical trials

IVRs comprising a silicone matrix that releases the ARV drug dapivirine, over one month is the only microbicide evaluated in a phase III clinical trial demonstrating efficacy (27 and 31%) in preventing HIV transmission in women as determined in The Ring Study and ASPIRE studies (11, 12). The dapivirine ring is currently being evaluated in …

Microbicides demonstrating efficacy in clinical trials Read More »

Oral PrEP in MSM

The microbicide field has been overtaken by oral PrEP comprising of ARVs (i.e. tenofovir and emtricitabine [Truvada]) normally used for HIV treatment (see Biomedical Prevention Section). Several clinical trials (iPrEX, Partners PrEP, TDF2, PROUD) have demonstrated the efficacy of oral daily PrEP in MSM and high-risk heterosexual men and women including serodiscordant couples (13-15). The …

Oral PrEP in MSM Read More »

Oral PreP in women

While the TDF2 (15) and Partners PrEP (14) studies indicate that oral PrEP can work in women, other trials in high-risk women (FEM-PrEP and VOICE) showed no efficacy (20, 21). This lack of efficacy was largely attributed to poor adherence (22). However, other factors such HIV subtype exposure, mode of transmission, and the percent of …

Oral PreP in women Read More »

Long-acting injectables and implants

There are exciting advances in the development of long-acting injectable and implants to deliver sustained levels of ARV drugs (25, 26). However, like oral PrEP these modalities deliver the drug systemically, which may discourage their use. Major advantages of these delivery strategies are that dosing is discrete and independent of coitus, which should maximise adherence …

Long-acting injectables and implants Read More »

Multipurpose prevention technologies (MPTs)

Multipurpose prevention technologies (MPTs) are designed to target HIV prevention as well as an additional indication such as preventing unintended pregnancies or transmission of other sexually transmissible infections (STIs) such as herpes simplex virus (HSV) infection. Delivery strategies under development include sustained release IVRs (27). While a ring with additional indications, such as preventing pregnancy, …

Multipurpose prevention technologies (MPTs) Read More »

HIV Management Guide for Clinical Care and ARV Guidelines